Your browser doesn't support javascript.
loading
Development of an accelerated cellular model for early changes in Alzheimer's disease.
Xue, Huijing; Gate, Sylvester; Gentry, Emma; Losert, Wolfgang; Cao, Kan.
Afiliación
  • Xue H; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, 20742, USA.
  • Gate S; Institute of Physical Sciences, University of Maryland, College Park, MD, 20742, USA.
  • Gentry E; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, 20742, USA.
  • Losert W; Institute of Physical Sciences, University of Maryland, College Park, MD, 20742, USA.
  • Cao K; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, 20742, USA. kcao@umd.edu.
Sci Rep ; 13(1): 18384, 2023 10 26.
Article en En | MEDLINE | ID: mdl-37884611
ABSTRACT
Alzheimer's Disease (AD) is a leading cause of dementia characterized by amyloid plaques and neurofibrillary tangles, and its pathogenesis remains unclear. Current cellular models for AD often require several months to exhibit phenotypic features due to the lack of an aging environment in vitro. Lamin A is a key component of the nuclear lamina. Progerin, a truncated protein resulting from specific lamin A mutations, causes Hutchinson-Gilford Progeria Syndrome (HGPS), a disease that prematurely ages individuals. Studies have reported that lamin A expression is induced in the brains of AD patients, and overlapping cellular phenotypes have been observed between HGPS and AD cells. In this study, we investigated the effects of exogenous progerin expression on neural progenitor cells carrying familial AD mutations (FAD). Within three to four weeks of differentiation, these cells exhibited robust AD phenotypes, including increased tau phosphorylation, amyloid plaque accumulation, and an elevated Aß42 to Aß40 ratio. Additionally, progerin expression significantly increased AD cellular phenotypes such as cell death and cell cycle re-entry. Our results suggest that progerin expression could be used to create an accelerated model for AD development and drug screening.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Progeria / Enfermedad de Alzheimer Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Progeria / Enfermedad de Alzheimer Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
...